| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/11/2007 | EP1351938B1 Phenyl derivatives |
| 04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 04/11/2007 | EP1239884B1 Methods for preparing pharmaceutical formulations |
| 04/11/2007 | EP1012191B1 Method for obtaining high-purity vwf or factor viii/vwf complex |
| 04/11/2007 | EP1005492B1 Purification of von willebrand factor by cation exchanger chromatography |
| 04/11/2007 | CN1943776A The onion blood pressure decreasing capsule, oral liquid, tablet and their preparation method |
| 04/11/2007 | CN1943715A A Chinese traditional medicinal injection preparation and its preparation method |
| 04/11/2007 | CN1943694A A Chinese traditional medicinal composition for treating renal deficiency, edema, lumbago and gonalgia, etc. |
| 04/11/2007 | CN1943667A The Chinese traditional medicinal powder for hemostasia, acesodyne, myogenic, sore, healing and its preparation method |
| 04/11/2007 | CN1309826C Nattokinase purification process |
| 04/11/2007 | CN1309760C Poly asparaginyl aminoacetic acid, alanine and lysine and its preparation method and medicament purpose |
| 04/11/2007 | CN1309741C Iron dextrin compounds for the treatment of iron deficiency anaemia |
| 04/11/2007 | CN1309734C Polypeptides involved in immune response |
| 04/11/2007 | CN1309717C 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof |
| 04/11/2007 | CN1309704C Anthranyl amides and their use as medicaments |
| 04/11/2007 | CN1309416C Pharmaceutical composition |
| 04/11/2007 | CN1309409C Chinese medicine composite for treatment and prevention of cerebral arteries obstruction |
| 04/11/2007 | CN1309394C Rue extract preparing method |
| 04/11/2007 | CN1309369C Maluoning powder injection for injection and its preparing method |
| 04/10/2007 | US7202341 Stabilized hemoglobin solutions |
| 04/10/2007 | US7202278 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; for treatment of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
| 04/10/2007 | US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity |
| 04/10/2007 | US7202236 Salts of inhibitors of trypsin-like proteases such as thrombin, e.g., a sulfonate salt of Ph(3-Cl)(5-OCHF2) (R)CH(OH)C(O) (S)Aze-Pab(OMe), combined with a cellulose ether neutral gelling polymer for the treatment or prevention of thrombosis |
| 04/10/2007 | US7202208 Erythropoietin composition |
| 04/10/2007 | US7202065 Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme |
| 04/10/2007 | US7201898 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/10/2007 | CA2407100C 1-aroyl-piperidinyl benzamidines |
| 04/10/2007 | CA2377746C N-pyrazole a2a receptor agonists |
| 04/10/2007 | CA2364199C Novel bicyclic derivatives of aminopyrazinone, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2191746C [a]-annelated pyrrole derivatives and pharmaceutical use thereof |
| 04/10/2007 | CA2177772C Pharmaceutical compositions containing irbesartan |
| 04/10/2007 | CA2162306C Use of dl-(+/-)-.alpha.-lipoic acid, d-(+)-.alpha.-lipoic acid, .alpha. lipoic acid in reduced or oxidized form or salts for treating circulatory disorders |
| 04/10/2007 | CA2154477C Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation |
| 04/10/2007 | CA2148194C Cyclopeptides of the formula i |
| 04/10/2007 | CA2102447C Cyclopeptides |
| 04/05/2007 | WO2007037554A1 Adsorbent for advanced glycation endproducts |
| 04/05/2007 | WO2007036769A1 Aminothiazole derivatives as agonists of the thrombopoietin receptor |
| 04/05/2007 | WO2007036306A1 2-aminoethoxyacetic acid derivatives and their use in treating thromboembolic disorders |
| 04/05/2007 | WO2007036016A1 Therapeutic molecules and their uses |
| 04/05/2007 | WO2007017154A3 Human inhibitory anti-factor viii antibodies binding to the a2 domain |
| 04/05/2007 | WO2003070751A3 Partial peptide mimetics and methods |
| 04/05/2007 | US20070078153 4-Oxoimidazolidine-2-spiropiperidine derivatives |
| 04/05/2007 | US20070077627 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 04/05/2007 | US20070077242 Tumor necrosis factor specific immunoglobulin for use in treatment and prevention of tumor disorder; tissue targeted therapy |
| 04/05/2007 | DE102005047563A1 New modification of specific substituted thiophene carboxamide, useful for prevention and treatment of thrombo-embolic disease, has higher solubility than known modifications |
| 04/05/2007 | DE102005047561A1 Drug delivery system, useful to treat and/or prevent e.g. thromboembolic disease, comprises 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo -4-morpholinyl)-phenyl)-1,3-oxazolidine-5-yl)-methyl)-2-thiophene carboxamide with fast release active substance |
| 04/05/2007 | CA2624686A1 Therapeutic molecules and their uses |
| 04/05/2007 | CA2623294A1 2-aminoethoxyacetic acid derivatives and their use |
| 04/04/2007 | EP1770161A2 BMP-11 compositions |
| 04/04/2007 | EP1770101A1 Antibodies against caspase-8, their preparation and use |
| 04/04/2007 | EP1768690A1 Methods or use of lamin b1 nuclear antigen, fragments and compositions thereof, for inhibiting or reducing a thrombotic event |
| 04/04/2007 | EP1768675A1 Combination therapies employing nicotinic acid derivatives or fibric acid derivatives |
| 04/04/2007 | EP1259595B1 Integrin antagonists |
| 04/04/2007 | EP1029548B1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 04/04/2007 | EP0951292B1 Treating an ischemic disorder and improving stroke outcome |
| 04/04/2007 | CN1940068A Novel receptor nucleic acids and polypeptides |
| 04/04/2007 | CN1940065A Oriented mutant gene engineering barr kinase and its use |
| 04/04/2007 | CN1939930A Low-molecular TPO agonist antibodies |
| 04/04/2007 | CN1939922A 5H-thiophene [3,4-C] pyrrole-4,6-diketone derivative for inhibiting cell release tumor necrosis factor |
| 04/04/2007 | CN1939895A Compound, composition and method for preventing from neurodegeneration in injury of central nervous system |
| 04/04/2007 | CN1939529A Compositions and methods for modulating connexin hemichannels |
| 04/04/2007 | CN1939517A Instant-eliminating bag for expansion and dropsy |
| 04/04/2007 | CN1939469A Chinese medicinal plaster with analgetic, hemostatic, repercussive and sarcogenic functions |
| 04/04/2007 | CN1939440A Animal medicament with anthemorrhagic toxin-removing and dysentery-eliminating functions and its preparation |
| 04/04/2007 | CN1939434A Quality control of medicine composition |
| 04/04/2007 | CN1939433A Quality control of Chinese medicinal compound preparation |
| 04/04/2007 | CN1939430A Yiqing dispersing tablets |
| 04/04/2007 | CN1939399A Blood stream-breaking dispersing tablets |
| 04/04/2007 | CN1939393A Quality control of Chinese-medicine compound preparation |
| 04/04/2007 | CN1939392A Quality control of Chinese medicine compound preparation |
| 04/04/2007 | CN1939391A Quality control of Chinese-medicine compound preparation |
| 04/04/2007 | CN1939387A Compound Sanchi preparation |
| 04/04/2007 | CN1939378A Preparation of blood-activating and pain-stopping capsules |
| 04/04/2007 | CN1939372A Quality control of medicine composition |
| 04/04/2007 | CN1939371A Quality control of Chinese-medicinal compound preparation |
| 04/04/2007 | CN1939370A Animal medicament with heat-clearing and dampness-resolving functions and its preparation |
| 04/04/2007 | CN1939368A Quality control of Chinese medicinal compound preparation |
| 04/04/2007 | CN1939364A Production and use for Chinese Angelica water-phase extract |
| 04/04/2007 | CN1939357A Preparation of Ginkgo Damo injection |
| 04/04/2007 | CN1939352A Animal pharmacon with heat-clearing, toxicity-relieving, worm-expelling and blood-cooling functions and its production |
| 04/04/2007 | CN1939344A Donkey-hide gelatin oral preparation and its making method |
| 04/04/2007 | CN1939327A Pharmaceutical usage of neolinarin, linarin and their composition |
| 04/04/2007 | CN1939324A Medical usage of periplocin A and E |
| 04/04/2007 | CN1939322A Absorbing meneusapogenin compound nebula |
| 04/04/2007 | CN1939290A Medical usage of colchicine and its derivative |
| 04/04/2007 | CN1308448C Degraded TPO agonist antibody |
| 04/04/2007 | CN1308438C Compositions including ammonia oxidizing bacteria and methods of using same |
| 04/04/2007 | CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 04/04/2007 | CN1308320C Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 04/04/2007 | CN1308311C Novel pyridine- and quinoline-derivatives |
| 04/04/2007 | CN1308032C Medicinal composition for treating dysfunctional uterine bleeding and its preparation method |
| 04/04/2007 | CN1308022C Chinese medicinal oral liquid for preventing and treating apoplexy sequelae |
| 04/04/2007 | CN1307981C Xuening dripping pill having hemostatic function and its preparing method |
| 04/04/2007 | CN1307973C Orally disintegrating tablet for dredging vascular thrombus and its preparation process |
| 04/04/2007 | CN1307909C Technological process for preparing beverage, oral liquor, granule, and antitoxic tablet from fern root |
| 04/03/2007 | US7199219 Polypeptides derived from vitamin D nuclear receptor, and their uses in particular for screening vitamin D analogues |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists |
| 04/03/2007 | US7199133 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents |
| 04/03/2007 | US7199130 Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists |